This is an HTML version of an attachment to the Freedom of Information request 'Industry, vaccines and patents (DG SANTE)'.

From:
CAB-DOMBROVSKIS)
To:
CAB DOMBROVSKIS CONTACT
Subject:
FW: Kind request for a dialogue on the EU vaccines export authorisation scheme
Date:
vendredi 12 février 2021 23:04:42
Attachments:
Vaccines export authorisation scheme letter.pdf
 
 
From: 
@efpia.eu> 
Sent: Friday, February 12, 2021 6:38 PM
To: KYRIAKIDES Stella (CAB-KYRIAKIDES) <
@ec.europa.eu>;
DOMBROVSKIS Valdis (CAB-DOMBROVSKIS) 
@ec.europa.eu>;
BRETON Thierry (CAB-BRETON) <
@ec.europa.eu>
Cc: 
 (TRADE) <S
@ec.europa.eu>; 
 (GROW)
<
@ec.europa.eu>; GALLINA Sandra (SANTE)
@ec.europa.eu>; 
Medicines for Europe
@medicinesforeurope.com>; 
@businesseurope.eu>;
@efpia.eu>; 
 Medicines for Europe
@medicinesforeurope.com>; 
@businesseurope.eu>
Subject: Kind request for a dialogue on the EU vaccines export authorisation scheme
 
Dear Executive Vice President, dear Commissioners, 
 
I hope this email finds you well despite the ongoing pandemic.
 
I am writing to you on behalf of EFPIA, Business Europe and Medicines for
Europe to share the attached letter regarding the export authorisation scheme, for
your kind consideration. 
 
While we fully share and support the objective of increasing vaccines production
and access of vaccines for European citizens, we have serious concerns with the
scheme that we raise in our letter. 
 
We would like to respectfully request a dialogue with you to address some of the
export authorisation scheme's unintended consequences that could delay production
as well as vaccine testing. 
 
Thank you in advance for your time and kind consideration and our best wishes for
a pleasant weekend,
 
 on behalf of EFPIA, Business Europe and Medicines for Europe
 
 
EFPIA - European Federation of Pharmaceutical Industries and Associations
Leopold Plaza Building
Rue du Trône 108
B-1050 Bruxelles
Tel: 
 (Direct Line)
Tel: +3226262555 (Switchboard)
Email: 
@efpia.eu


www.efpia.eu 
For more information related to COVID-19 see: https://efpia.eu/news-
events/the-efpia-view/statements-press-releases/european-
pharmaceutical-industry-response-to-coronavirus/